Early Microglial Priming In Alzheimer’S Disease Revealed By ME-Seq
Understanding Alzheimer’s disease, a progressive brain disorder, often involves studying microglia, the brain’s own immune cells. These cells play a crucial role in maintaining brain health, but in diseases like Alzheimer’s, they can become dysfunctional. Scientists have long suspected that changes in how genes are regulated, known as epigenetic modifications, contribute to this dysfunction, but studying these changes at a detailed level has been challenging.
This new research introduces an innovative and highly efficient technology called ME-seq. This tool allows scientists to simultaneously examine three critical aspects of gene regulation within individual brain cells: DNA methylation (chemical tags on DNA that can turn genes on or off), gene expression (which genes are active), and chromatin accessibility (how tightly DNA is packed, affecting gene readability). What’s more, ME-seq achieves this at a significantly lower cost, making large-scale studies more feasible.
Using ME-seq, researchers generated an extensive map of gene regulation in the brains of aging and Alzheimer’s disease mouse models. They discovered that as Alzheimer’s progresses, there are notable shifts in the types of cells present in the brain, alongside an acceleration of “epigenetic aging” – changes in DNA methylation patterns linked to aging. Crucially, they observed an expansion of “disease-associated microglia” (DAM), a specific state of microglia found in neurodegenerative diseases.
The study revealed that DNA methylation acts as an early “priming layer,” essentially setting the stage for microglial changes before the genes themselves are fully activated. They also identified a specific protein, IRF1, as a key “gatekeeper” that controls the activation of these disease-associated microglia, and found that IRF1’s activity is sensitive to DNA methylation.
These findings highlight ME-seq as a powerful new tool for dissecting the complex epigenetic landscape of the brain. More importantly, the research uncovers DNA methylation as a primary coordinator of how brain cells change their state during aging and in Alzheimer’s disease, offering new avenues for understanding and potentially targeting the early stages of this devastating condition.
Source: link to paper